Tumor regression induced by intratumoral injection of DNA coding for human interleukin 12 into melanoma metastases in gray horses

Journal of Molecular Medicine

Volumn 78, Issue 12, 2001, Pages 692-702

  Heinzerling, Lucie M ^a   Feige, Karsten ^b   Rieder, Stefan ^c   Akens, Margarete K ^b   Dummer, Reinhard ^a   Stranzinger, Gerald ^c   Moelling, Karin ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c ETH ZURICH   (Switzerland)

Author keywords

Cytokine; Large animal; Melanoma model; Plasmid DNA treatment; Species specificity

Indexed keywords

ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CELL PROTECTION; FLOW CYTOMETRY; GENETIC PREDISPOSITION; GROWTH INHIBITION; HORSE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MELANOMA; NONHUMAN; PLASMID; SPECIES DIFFERENCE; TUMOR GROWTH; TUMOR REGRESSION;

EID: 0034465697     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090000165     Document Type: Article

References (55)

1. Analysis of the melanoma epidemic, both apparent and real: Data from the 1973 through 1994 surveillance, epidemiology, and end results program registry
2. Treatment of malignant melanoma
3. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells
4. Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1
5. Clinical and immune responses in advanced melanoma patients immunized with an anti-idiotype antibody mimicking disialoganglioside GD2
6. Rationale and methods for the use of nude mice to study the biology and therapy of human cancer metastasis
7. Metastatic potential of human melanoma cells in nude mice - Characterisation of phenotype, cytokine secretion and tumour-associated antigens
8. Human xenografts, human skin and skin reconstructs for studies in melanoma development and progression
9. Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis
10. Grey horse melanotic condition: A pigmentary disorder
11. A comparative genetic approach for the investigation of aging gray horse melanoma
12. Equine leucocyte antigens in sarcoid affected horses
13. Histological survey of tumours of the horse, with particular reference to those of the skin
14. Tumors of the skin and soft tissues
15. Large animal dermatology
16. Equine melanocytic tumors: A retrospective study of 53 horses (1988 to 1991)
17. Morphogenesis of compound melanosomes in melanoma cells of a gray horse
18. Cimetidine for treatment of melanomas in three horses
19. Excision of melanomas in horses
20. In vivo gene therapy with interleukin-12 inhibits primary vascular tumor growth and induces apoptosis in a mouse model
21. Intratumoral delivery of IL-12 gene by polyvinyl polymeric vector system to murine renal and colon carcinoma results in potent antitumor immunity
22. Long-lasting anti-metastatic efficiency of interleukin 12-encoding plasmid DNA
23. The study of cutaneous melanomas in Camargue-type gray-skinned horses (2): Epidemiological survey
24. In vivo protective anti-HIV immune responses in non-human primates through DNA immunization
25. Nucleic acid vaccination of sheep: Use in combination with a conventional adjuvanted vaccine against Taenia ovis
26. Protection of pigs against Aujeszky's disease by DNA vaccination
27. Bovine herpesvirus 1: Immune response in mice and cattle injected with plasmid DNA
28. First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: Safety and host response
29. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine
30. Gene therapy for myocardial angiogenesis: Initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia
31. Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: Preliminary clinical results
32. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia
33. Synergy between recombinant interleukin 2 (rIL 2) and IL 2-depleted lymphokine-containing supernatants in facilitating allogeneic human cytolytic T lymphocyte responses in vitro
34. Comparative analysis of equine lymphocyte subsets in whole blood and gradient-purified samples
35. Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells
36. Real time quantitative PCR
37. Serum S100-a marker for disease monitoring in metastatic melanoma
38. Immune responses to hepatitis B virus surface and core antigens in mice, monkeys, and pigs after Accell particle-mediated DNA immunization
39. Immunization of pigs with a particle-mediated DNA vaccine to influenza A virus protects against challenge with homologous virus
40. Immunization of dogs and cats with a DNA vaccine against rabies virus
41. Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo
42. Cytokine gene therapy of cancer using gene gun technology: Superior antitumor activity of interleukin-12
43. Functional and structural comparison of cytokines in different species
44. Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor
45. Cloning and expression of murine IL-12
46. Interleukin-12: A cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes
47. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes
48. Induction of interferon gamma production by natural killer cell stimulatory factor: Characterization of the responder cells and synergy with other inducers
49. Tumor cell responses to IFN-gamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis
50. Intratumoral pharmacokinetics and in vivo gene expression of naked plasmid DNA and its cationic liposome complexes after direct gene transfer
51. Gene expression and antitumor effects following direct interferon (IFN)-gamma gene transfer with naked plasmid DNA and DC-chol liposome complexes in mice
52. Polycation-based DNA complexes for tumor-targeted gene delivery in vivo
53. The role of CpG dinucleotides in DNA vaccines